Clinical trials recruiting for Chronic hepatitis B
44
Recruiting trials
2
US states with sites
10
Countries
7%
Accept healthy volunteers
Phase breakdown
Drugs and treatments being studied
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Maryland | 3 |
| New York | 1 |
Top cities
Self-screener
Recruiting trials
- A Clinical Study Evaluating the Pharmacokinetic Characteristics and Safety of AHB-137 Injection in Participants With Mild to Moderate Liver Dysfunction and Those With Normal Liver Function.
- A Multicenter Study of AHB-137 Injection Combined With Other Hepatitis B Drugs
- A Multicenter, Randomized, Open, Parallel-designed Study to Evaluate the Efficacy and Safety of HRS-5635 Injection Alone or in Combination With Other Agents in Patients Treated for Chronic Hepatitis B
- A Novel Combination Therapeutic Strategy Aiming to Functional Cure for Chronic Hepatitis B Virus Infection (Sustained HBsAg Loss) (A)
- A Novel Combination Therapeutic Strategy Aiming to Functional Cure for Chronic Hepatitis B Virus Infection (Sustained HBsAg Loss) (B)
- A Randomized, Double-blind, Placebo-controlled Phase IIa Clinical Study to Evaluate the Safety and Efficacy of GST-HG131 Tablets in Patients With Chronic Hepatitis B
- A Small Sample Prospective Clinical Study of Azvudine Tablets to Promote Clinical Cure in Patients With Chronic Hepatitis B
- A Study to Evaluate AHB-137 Injection in Treatment-naïve Participants With Chronic Hepatitis B
- A Study to Evaluate the Efficacy and Safety of AHB-137 Injection in Participants With Chronic Hepatitis B (CHB)
- ASC22 Combined With Peg-IFNa in Achieving Functional Cure in Patients With Chronic Hepatitis B Virus Infection
- Adaptability of an Undetectable = Untransmissible Model for HBV
- Assessment of Treatment Adherence and Associated Factors in Chronic HepB Patients Supported by HBVCare
- Cessation of Long Term NAs vs. Keeping on NAs Among CHB Patients (CNAVK)
- Clinical Outcomes of HBeAg-negative CHB Patients With Indeterminate Phase
- Combined Use of Bacteroides Fragilis and BCAAs on HBsAg Clearance
- Efficacy and Safety of Antiviral Therapy With Peg-interferon for Chronic Hepatitis B Complicated With Nonalcoholic Fatty Liver Disease（OCEAN PROJECT）
- Exploring the Genome-wide Association Study of the Population With Clinical Cure Advantage in the Treatment of Chronic Hepatitis B With Long-acting Interferon
- Fine Needle Aspiration (FNA) Evaluation of the Intrahepatic HBV Reservoir and Its Immunological Characteristics in Chronically HBV-infected Patients
- Follow-up of Chronic Hepatitis B Patients With Comorbid Nonalcoholic Fatty Liver Disease
- From Fungus to Virus, Investigating the Safety and Efficacy of Terbinafine in Chronic Hepatitis B Patients
- HBV-Specific TCR-T Cell Therapy Combined With Nucleos(t)Ide Analogues in Chronic Hepatitis B Patients
- Hepatitis Delta Virus Infection: Cross-sectional Study in Patients With Chronic Hepatitis B Virus Infection
- Hospital-Based Management of Patients With Chronic Hepatitis B Virus Infection
- Intrahepatic and Peripheral Responses to Imdusiran (AB-729) in Chronic Hepatitis B
- Long-term Follow-up Study to Evaluate Participants With Chronic Hepatitis B (CHB) Previously Treated With AHB-137 Injection
- Long-term Outcomes of Anti-viral Therapies in Patients With Chronic Viral Hepatitis B
- MR Elastography for Assessing Liver Fibrosis in Chronic Hepatitis B
- Molecular Characteristics of Hepatitis B Virus Integration, Mutation, and Drug Resistance
- Observation Study on Reducing the Risk of Liver Cancer Associated With Hepatitis B (Zhiyuan) Project.
- Pegylated Interferon α in Previously Interferon-treated CHB（Leading Study）
- Phase 1b, Open-label Study of Tune-401 to Assess Safety, PK and PD in Adults With Chronic Hepatitis B
- Research on Clinical Recovery and Maintenance Strategies for CHB
- Risk Factors for Hepatic Inflammation, Fibrosis and Prognosis in Patients With CHB and NAFLD
- SA1211 Injection Phase 1 Study
- SGLT2i to Prevent of Liver Complications in Patients With CHB and Diabetes Mellitus
- Safety and Efficacy of TAF to Prevent MTCT of HBV in Middle/Late Pregnancies With High HBV DNA Load
- Study of GST-HG131&141 Tablets Compared With Placebo in Patients With Chronic Hepatitis B
- Study of Tenofovir Alafenamide in HBV-Infected Pregnant Women
- TLR-9 Adjuvanted Vaccination for Chronic Hepatitis B
- The Establishment of Korean Hepatitis B Patients Cohort
- TherVacB - A Heterologous Protein Prime/MVA Boost Therapeutic Hepatitis B Vaccine Candidate
- Therapeutic Effects and Long-term Follow-up After Ending Nucleos(t)Ide Analogs Therapy in Chronic Hepatitis b
- To Evaluate the Efficacy, Safety and Population Pharmacokinetics of GST-HG141 in Patients With Chronic Hepatitis B (CHB) Who Have an Inadequate Response to Antiviral Drug Treatment
- VIR-2218 and Peginterferon Alfa-2a for Chronic Hepatitis B
Related conditions
Trials recruiting for Chronic hepatitis B often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Chronic hepatitis B trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.